Revenue: The sum of all revenue fields included for a company's operating activities.
9 Meters Biopharma, Inc. (MNTRQ) Revenue data is not available for the most recently reported fiscal quarter, ending 2023-03-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-13.87M |
|
-- |
|
-- |
|
$12.79M |
|
$-12.79M |
|
$-1.08M |
|
$-13.87M |
|
$-13.87M |
|
$-13.87M |
|
$-13.87M |
|
$-13.87M |
|
$-13.87M |
|
$-12.79M |
|
$-12.21M |
|
13.59M |
|
13.59M |
|
$-1.02 |
|
$-1.02 |
|
| Balance Sheet Financials | |
$9.20M |
|
$0.01M |
|
$0.12M |
|
$9.31M |
|
$15.58M |
|
-- |
|
$0.03M |
|
$15.61M |
|
$-6.30M |
|
$-6.30M |
|
$-6.30M |
|
14.34M |
|
| Cash Flow Statement Financials | |
$-9.75M |
|
-- |
|
$-12.29M |
|
$29.66M |
|
$7.62M |
|
$-22.04M |
|
$0.74M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.59 |
|
-- |
|
-- |
|
-- |
|
-0.81 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.75M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
220.16% |
|
220.16% |
|
-148.91% |
|
220.16% |
|
$-0.44 |
|
$-0.72 |
|
$-0.72 |
|